{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:27:05Z","timestamp":1783013225902,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The genetic and environmental factors influencing an individual\u2019s susceptibility to develop Guillain\u2013Barr\u00e9 syndrome (GBS) remain largely unidentified. This study aims to evaluate the genetically predicted associations between GBS and candidate autoimmune diseases using a Mendelian randomization (MR) framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genetic instruments for autoimmune diseases were extracted from large-scale genome-wide association study (GWAS) datasets. Following stringent quality control, seven autoimmune diseases were ultimately retained for the primary analysis. Summary statistics for GBS were obtained from the FinnGen consortium. We employed the inverse variance weighted (IVW) method as the primary approach, supplemented by sensitivity analyses to ensure robustness. Furthermore, a high-throughput two-step MR screening of 731 immune traits was integrated to explore potential biological mediators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Genetic liability to type 1 diabetes was suggestively associated with an increased risk of GBS [OR (95% CI)\u2009=\u20091.26 (1.04\u20131.52),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0176]. Conversely, genetic predisposition to psoriasis vulgaris showed a suggestive protective association [OR (95% CI)\u2009=\u20090.784 (0.623\u20130.986),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0375]. No significant or suggestive associations were observed for rheumatoid arthritis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.990), sarcoidosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.993), systemic lupus erythematosus (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.240), asthma (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.906), or Graves\u2019 disease (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.926). No circulating immune trait emerged as a significant mediator between these conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies suggestive genetically predicted associations between specific autoimmune diseases and GBS susceptibility, specifically a potential risk-increasing effect of type 1 diabetes and a protective effect of psoriasis vulgaris. The absence of significant peripheral immune mediators suggests that these neuro-immune interactions may be driven by more localized or complex tissue-resident mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04957-8","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:44:57Z","timestamp":1778323497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between Guillain\u2013Barr\u00e9 syndrome and 7 autoimmune diseases: a mendelian randomization study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jialei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"4957_CR1","doi-asserted-by":"publisher","unstructured":"Liu S, Zhang WW, Jia L, Zhang H-L. Guillain-Barr\u00e9 syndrome: immunopathogenesis and therapeutic targets. Expert Opin Ther Targets. 2024;1\u201313. https:\/\/doi.org\/10.1080\/14728222.2024.2330435.","DOI":"10.1080\/14728222.2024.2330435"},{"key":"4957_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, De Vries CS. The epidemiology of Guillain-Barr\u00e9 Syndrome worldwide. Neuroepidemiology. 2009;32:150\u201363. https:\/\/doi.org\/10.1159\/000184748.","journal-title":"Neuroepidemiology"},{"key":"4957_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A. Outcome and its predictors in Guillain\u2013Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 2012;83:711\u20138. https:\/\/doi.org\/10.1136\/jnnp-2011-301882.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4957_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, Van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016;388:717\u201327. https:\/\/doi.org\/10.1016\/S0140-6736(16)00339-1.","journal-title":"Lancet"},{"key":"4957_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-07163-3","author":"K Li","year":"2023","unstructured":"Li K, Ouyang Y, Yang H. Myasthenia gravis and five autoimmune diseases: a bidirectional mendelian randomization study. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2023. https:\/\/doi.org\/10.1007\/s10072-023-07163-3.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"4957_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10:486\u201396. https:\/\/doi.org\/10.1002\/jrsm.1346.","journal-title":"Res Synth Methods"},{"key":"4957_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"key":"4957_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614. https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"JAMA"},{"key":"4957_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345. https:\/\/doi.org\/10.1038\/s41588-020-0684-4.","journal-title":"Nat Genet"},{"key":"4957_CR10","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408. https:\/\/doi.org\/10.7554\/eLife.34408.","journal-title":"eLife"},{"key":"4957_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fgene.2020.00157","volume":"11","author":"TA Myers","year":"2020","unstructured":"Myers TA, Chanock SJ, Machiela MJ. LDlinkR: An R package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet. 2020;11:157. https:\/\/doi.org\/10.3389\/fgene.2020.00157.","journal-title":"Front Genet"},{"key":"4957_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364. https:\/\/doi.org\/10.1093\/ije\/dyr036.","journal-title":"Int J Epidemiol"},{"key":"4957_CR13","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081.","journal-title":"PLoS Genet"},{"key":"4957_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"key":"4957_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample mendelian randomization. Genet Epidemiol. 2016;40:597\u2013608. https:\/\/doi.org\/10.1002\/gepi.21998.","journal-title":"Genet Epidemiol"},{"key":"4957_CR16","doi-asserted-by":"publisher","unstructured":"Levison LS, Thomsen RW, Sindrup SH, Andersen H. Association of hospital-diagnosed infections and antibiotic use with risk of developing Guillain-Barr\u00e9 Syndrome. Neurology. 2021;96. https:\/\/doi.org\/10.1212\/WNL.0000000000011342.","DOI":"10.1212\/WNL.0000000000011342"},{"key":"4957_CR17","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1111\/ene.15516","volume":"29","author":"LS Levison","year":"2022","unstructured":"Levison LS, Thomsen RW, Andersen H. Guillain\u2013Barr\u00e9 syndrome following influenza vaccination: a 15-year nationwide population\u2010based case\u2013control study. Eur J Neurol. 2022;29:3389\u201394. https:\/\/doi.org\/10.1111\/ene.15516.","journal-title":"Eur J Neurol"},{"key":"4957_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","volume":"12","author":"JA Goodfellow","year":"2016","unstructured":"Goodfellow JA, Willison HJ. Guillain\u2013Barr\u00e9 syndrome: a century of progress. Nat Rev Neurol. 2016;12:723\u201331. https:\/\/doi.org\/10.1038\/nrneurol.2016.172.","journal-title":"Nat Rev Neurol"},{"key":"4957_CR19","doi-asserted-by":"publisher","unstructured":"Levison LS, Thomsen RW, Sindrup SH, Andersen H. Association between incident cancer and guillain-barr\u00e9 syndrome development: a nationwide case-control study. Neurology. 2022;98. https:\/\/doi.org\/10.1212\/WNL.0000000000200015.","DOI":"10.1212\/WNL.0000000000200015"},{"key":"4957_CR20","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1111\/ene.15955","volume":"30","author":"LS Levison","year":"2023","unstructured":"Levison LS, Thomsen RW, Andersen H. Hospital-diagnosed morbidities and recent surgery as risk factors for developing Guillain-Barr\u00e9 syndrome. Eur J Neurol. 2023;30:3277\u201385. https:\/\/doi.org\/10.1111\/ene.15955.","journal-title":"Eur J Neurol"},{"key":"4957_CR21","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/s41433-025-03715-3","volume":"39","author":"Y Mi","year":"2025","unstructured":"Mi Y, Chen L, Liao N, Wan M. Mendelian randomization analysis revealed a gut microbiota-eye axis in acute anterior uveitis. Eye. 2025;39:1562\u201370. https:\/\/doi.org\/10.1038\/s41433-025-03715-3.","journal-title":"Eye"},{"key":"4957_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5606\/ArchRheumatol.2017.6296","volume":"32","author":"B Sarg\u0131n","year":"2017","unstructured":"Sarg\u0131n B. Psoriasis and Guillain-Barr\u00e9 Syndrome: incidental or associated? Arch Rheumatol. 2017;32:273\u20134. https:\/\/doi.org\/10.5606\/ArchRheumatol.2017.6296.","journal-title":"Arch Rheumatol"},{"key":"4957_CR23","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1093\/rheumatology\/keac609","volume":"62","author":"H Liu","year":"2023","unstructured":"Liu H, Li Q, Li Q, Li X, Dai L. Guillain\u2013Barr\u00e9 syndrome is associated with ixekizumab in a patient with pustular psoriasis. Rheumatology. 2023;62:e161\u20133. https:\/\/doi.org\/10.1093\/rheumatology\/keac609.","journal-title":"Rheumatology"},{"key":"4957_CR24","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nat Rev Dis Primer. 2016;2:16082. https:\/\/doi.org\/10.1038\/nrdp.2016.82.","journal-title":"Nat Rev Dis Primer"},{"key":"4957_CR25","doi-asserted-by":"publisher","first-page":"e1178","DOI":"10.1002\/iid3.1178","volume":"12","author":"BA Suliman","year":"2024","unstructured":"Suliman BA. Potential clinical implications of molecular mimicry-induced autoimmunity. Immun Inflamm Dis. 2024;12:e1178. https:\/\/doi.org\/10.1002\/iid3.1178.","journal-title":"Immun Inflamm Dis"},{"key":"4957_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cmet.2013.05.001","volume":"17","author":"MY Donath","year":"2013","unstructured":"Donath MY, Dalmas \u00c9, Sauter NS, B\u00f6ni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 2013;17:860\u201372. https:\/\/doi.org\/10.1016\/j.cmet.2013.05.001.","journal-title":"Cell Metab"},{"key":"4957_CR27","doi-asserted-by":"publisher","first-page":"113272","DOI":"10.1016\/j.expneurol.2020.113272","volume":"328","author":"EE Ubogu","year":"2020","unstructured":"Ubogu EE. Biology of the human blood-nerve barrier in health and disease. Exp Neurol. 2020;328:113272. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113272.","journal-title":"Exp Neurol"},{"key":"4957_CR28","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung H-P. Guillain-barr\u00e9 syndrome. N Engl J Med. 2012;366:2294\u2013304. https:\/\/doi.org\/10.1056\/NEJMra1114525.","journal-title":"N Engl J Med"},{"key":"4957_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/01616412.2021.1965337","volume":"44","author":"Q Gong","year":"2022","unstructured":"Gong Q, Liu S, Xiao Z, Fu X, Lu Z. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barr\u00e9 syndrome. Neurol Res. 2022;44:121\u20137. https:\/\/doi.org\/10.1080\/01616412.2021.1965337.","journal-title":"Neurol Res"},{"key":"4957_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/ije\/dyx181","volume":"47","author":"N Auger","year":"2018","unstructured":"Auger N, Quach C, Healy-Profit\u00f3s J, Dinh T, Chass\u00e9 M. Early predictors of Guillain-Barr\u00e9 syndrome in the life course of women. Int J Epidemiol. 2018;47:280\u20138. https:\/\/doi.org\/10.1093\/ije\/dyx181.","journal-title":"Int J Epidemiol"},{"key":"4957_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10067-009-1154-7","volume":"28","author":"A Bouchra","year":"2009","unstructured":"Bouchra A, Benbouazza K, Hajjaj-Hassouni N. Guillain\u2013Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy. Clin Rheumatol. 2009;28:53\u20135. https:\/\/doi.org\/10.1007\/s10067-009-1154-7.","journal-title":"Clin Rheumatol"},{"key":"4957_CR32","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/ecco-jcc\/jjaa101","volume":"14","author":"MFC de Azevedo","year":"2020","unstructured":"de Azevedo MFC, Queiroz NSF, Dami\u00e3o AOMC. Guillain-barr\u00e9 syndrome in a crohn`s disease patient treated with vedolizumab. J Crohns Colitis. 2020;14:1788\u20139. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa101.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04957-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:10:28Z","timestamp":1783012228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04957-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4957"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04957-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No additional ethical approval was necessary for this study since publicly available summary statistics from genome-wide association studies (GWAS) were utilized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"425"}}